1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNo deadline specified on the page; historical awards suggest annual funding cycle but no current cycle deadline shown.
Sandy Rollman Ovarian Cancer Foundation Research Grant is sponsored by Sandy Rollman Ovarian Cancer Foundation. Funds research projects related to ovarian cancer, emphasizing early detection, treatment, and quality of life improvements.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Apply for a Grant | Sandy Rollman Ovarian Cancer Foundation The Foundation has awarded $4. 7 million and counting to ovarian cancer research. Every year, the Sandy Rollman Ovarian Cancer Foundation, Inc. funds research to find a cure for ovarian cancer, a screening test for early detection, breakthrough treatments and improve the quality of life for those living with ovarian cancer.
Special consideration is given to those researchers in the state of Pennsylvania. However, we welcome submissions from all cutting edge ovarian cancer researchers. Research proposals may be individual projects or part of a larger research project related to ovarian cancer.
All research proposals will be considered, however, special consideration will be given to local research projects. Consideration will be given to proposals leading to early detection, better treatment or a cure for ovarian cancer. Grant proposals for 2020 may not exceed $50,000.
Recommendation of award recipients will be made by Board Members and/or a member of the Medical Advisory Board. Proposals will be reviewed by a member of our Medical Advisory Board. The recommended will be discussed and voted on by Board Members.
Notification of action by the Sandy Rollman Ovarian Cancer Foundation, Inc. will be given within 30 days of receipt of the proposal. Proposals must include the following: Abstract of proposed research rationale of the study, aims, and an overview of research design and methods.
Summary of proposed research proposal (one paragraph) which describes the proposed research in terms an educated lay person would understand and describes the significance of the research to the patient population. (not to exceed 6 pages- not including references) Include any supporting information deemed essential. detailing direct cost expenditures.
All costs must be itemized. Sandy Rollman Ovarian Cancer Foundation, Inc. funds cannot be used for indirect costs, PI salary replacement, or travel. Information about PI should include: Statement of career goals of PI- (one page).
Curriculum vitae-including education, honors, professional experience, publications, grants. Contact information for PI which includes direct phone number and email from the relevant person overseeing institution, department or lab where the research will be conducted. detailing the expected chronological progress of research goals.
Send one original hard copy of the proposal to: Sandy Rollman Ovarian Cancer Foundation Additionally, send an electronic version of the proposal with attachments to Robin Cohen at robin@www. sandyovarian. org .
Dr. Timothy Yen at Fox Chase Cancer Center Dr. Katherine Aird at Hershey Medical Center American Cancer Society Grant Stand Up to Cancer Ovarian Cancer Dream Team Grant Dr. James Duncan at Fox Chase Cancer Center Stand Up to Cancer Ovarian Cancer Dream Team Grant Dr. Neil Johnson at Fox Chase Cancer Center Stand Up to Cancer Ovarian Cancer Dream Team Grant $50,000 to Dr. Garcia at University of Pennsylvania Stand Up to Cancer Ovarian Cancer Dream Team Grant $30,000 to Dr. Paul Cairns at Fox Chase Cancer Center Stand Up to Cancer Ovarian Cancer Dream Team Grant $50,000 to Dr.Kasia Urbanska at the University of Pennsylvania $50,000 to Drs.
George Coukos, MD, Ph. D. and Chunsheng Li, Ph.
D. at Penn Ovarian Cancer Research Center for Bi-specific T-cell Engagers (BiTEs) against tumor vasculature as an immune therapy for ovarian cancer. $50,000 to Erica Golemis, Ph.
D. at Fox Chase Cancer Center for Therapeutic targeting of ovarian cancer with HSP90 inhibitor ganetespib (STA-9090). $50,000 to Sandra Orsulic, Ph.
D. in collaboration with Beth Karlan, MD at Cedars-Sinai Medical Center for A Discriminatory Gene Signature for Early Ovarian Cancer Recurrence.
Key questions and narrative sections extracted from the solicitation.
Research abstract
Lay-person summary
Detailed proposal (max 6 pages)
Itemized budget
PI career statement and CV
Institutional recommendation letter
Project timeline
According to the current listing, eligibility includes: Researchers conducting ovarian cancer research; special consideration for Pennsylvania-based projects, but open to all researchers working on early detection, improved treatment, or cure for ovarian cancer. Confirm the full requirements in the official notice before applying.
The current listing shows up to $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Sandy Rollman Ovarian Cancer Foundation Research Grant is funded by Sandy Rollman Ovarian Cancer Foundation. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Pennsylvania. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article